ArticleDiscover oncology2024

ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway.

Yuming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.